tbs casein buffer (Surmodics IVD)
Surmodics IVD is a verified supplier 
Surmodics IVD manufactures this product 
93
Structured Review
Surmodics IVD
tbs casein buffer
Tbs Casein Buffer, supplied by Surmodics IVD, used in various techniques. Bioz Stars score: 93/100, based on 2 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/casein+blocking+buffer/Tris+Buffered+Saline%2FCasein+Block+%26+Diluent/pm36481208-78-19-26
Average 93 stars, based on 2 article reviews
Tbs Casein Buffer, supplied by Surmodics IVD, used in various techniques. Bioz Stars score: 93/100, based on 2 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/casein+blocking+buffer/Tris+Buffered+Saline%2FCasein+Block+%26+Diluent/pm36481208-78-19-26
Average 93 stars, based on 2 article reviews
tbs casein buffer - by Bioz Stars,
2026-11
93/100 stars
Images
Related Articles
other:Article Title: Development and validation of a novel immunogenicity assay to detect anti-drug and anti-PEG antibodies simultaneously with high sensitivity. Article Snippet: Polyethylene glycol (PEG) represents an effective strategy to improve the pharmacokinetic profile of a molecule as it extends the biotherapeutic's half-life, masks immunogenic epitopes or modifies its distribution.. The addition of one or multiple PEG moieties, in either linear or branched form, is known to carry the risk of potentially inducing an immunogenic response against PEG.. The importance of accurately quantifying anti-PEG antibodies during a clinical study is well recognized and stems from the fact that anti-PEG antibodies have been shown to negatively impact the efficacy of the biotherapeutic that the PEG is coupled to. Incubation:Article Title: A sensitive and drug tolerant assay for detecting anti-AAV9 antibodies using affinity capture elution. Article Snippet: Adeno-associated virus (AAV) based gene therapies are gaining significant momentum as a novel therapeutic modality.. However, a yet unsolved concern for using AAV as a vector is the high potential to elicit humoral and cellular responses, which are often exacerbated by pre-existing immunity due to exposure to wild type AAV.. Therefore, characterization of pre-existing and treatment emergent anti-AAV antibodies is of great importance to the development of AAV based gene therapies. Blocking Assay:Article Title: A sensitive and drug tolerant assay for detecting anti-AAV9 antibodies using affinity capture elution. Article Snippet: Adeno-associated virus (AAV) based gene therapies are gaining significant momentum as a novel therapeutic modality.. However, a yet unsolved concern for using AAV as a vector is the high potential to elicit humoral and cellular responses, which are often exacerbated by pre-existing immunity due to exposure to wild type AAV.. Therefore, characterization of pre-existing and treatment emergent anti-AAV antibodies is of great importance to the development of AAV based gene therapies. |